Navigation Links
FFF Enterprises Announces Return Guarantee For Flu Vaccine Through Its MyFluVaccine Program
Date:6/10/2009

Innovative program removes the risk of excess flu vaccine inventory with up to 100% Return Guarantee.

(Vocus) June 10, 2009 -- FFF Enterprises, Inc., the nation’s most trusted distributor of flu vaccine, has launched a first-of-its-kind up to 100% Return Guarantee Offer for 2009-10 seasonal flu vaccine orders. FFF, through its MyFluVaccine program, has introduced this unprecedented offer in its quest to eliminate the risks normally associated with flu vaccine ordering for healthcare providers.

“In these challenging economic times, there is no room for excess or waste,” says Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “This offer is the final step in removing the barriers to preparedness for healthcare providers on the front line who are so essential to winning the battle against flu. By offering a return guarantee on seasonal flu vaccine, we eliminate their worry of ending the flu season with leftover inventory. Now our customers can prepare for a potentially active vaccination season with the confidence of knowing that if their projections are high, they will not suffer an economic impact.”

FFF Enterprises’ MyFluVaccine works in coordination with healthcare providers so that clinics can schedule the exact arrival dates of flu vaccines, solving a universal problem within the flu vaccine marketplace: the uncertainty surrounding vaccine delivery. Historically, healthcare providers could never be certain when their flu vaccine orders would arrive, or even if they would receive the correct product and quantity. These conditions made it very difficult to plan for flu clinics, as providers could not be certain their vaccine would be there when their patients needed it. “We realized that the volatility in the marketplace created unnecessary frustration and risk, so we decided to do something about it,” Schmidt adds.

Certainty in supply and delivery was the first risk that MyFluVaccine addressed. The additional benefit of no pre-payment, a portfolio of products from the top manufacturers, FFF’s guaranteed safe channel and now up to 100% returnable vaccine makes MyFluVaccine a safe, reliable and smart choice for healthcare providers when ordering their flu vaccine.

With the 2009-2010 flu vaccine ordering season already in full swing, healthcare providers are encouraged to place their vaccine orders now. Thanks to the new FFF Enterprises 100% Return Guarantee for Fluvirin®, customers can order their vaccine supply confidently, without the potential financial burden of excess inventory when the season ends. For more information, and to learn about the terms and conditions regarding the return offers available from FFF Enterprises visit www.MyFluVaccine.com.

About FFF Enterprises, Inc.

FFF Enterprises, Inc., a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 21st year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF’s MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

###

Read the full story at http://www.prweb.com/releases/fluvaccine/fffenterprises/prweb2516204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
2. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
3. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
4. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China
5. CJPS Enterprises Spins Off New Company for Intellectual Property Marketing
6. Nu Skin Enterprises Announces Increase in Quarterly Dividend
7. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
8. Nu Skin Enterprises to Present at Bank of America 2008 Consumer Conference
9. CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
10. Nu Skin Enterprises to Announce First Quarter 2008 Results
11. CJPS Enterprises Announces a Series of Seminars on Automotive Diversification
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FFF Enterprises Announces Return Guarantee For Flu Vaccine Through Its MyFluVaccine Program
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: